New painkiller oliceridine tested against morphine in back surgery patients
NCT ID NCT06990893
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a newer painkiller called oliceridine with two standard drugs, morphine and sufentanil, for pain relief after lumbar spine surgery. Ninety adults will receive one of the three drugs through a patient-controlled pump. The main goal is to see how well each drug controls pain during movement six hours after surgery, and to check for side effects like nausea or drowsiness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oliceridine
- What this could lead to
- If oliceridine works as well as or better than morphine or sufentanil, it could offer a new option for managing pain after back surgery with possibly fewer side effects.
- What could go wrong
- This is a small, early-phase trial with only 90 participants, so results may not apply to everyone. The study is still recruiting, and it is not yet known if oliceridine is truly safer or more effective than existing drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MORPHINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anqing Hospital Anesthesiology
RECRUITINGAnqing, Anhui, 246003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a ketamine boost during surgery slash opioid needs?
- Can a new painkiller prevent breathing crises after surgery?
- Can a two-drug combo better tame prostate trouble?
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- New pain drug may cut Post-Surgery nausea
- Tiny study checks if novel bacterium is safe for people